INSURANCE COVERAGE FOR INFERTILITY TREATMENT SINCE APRIL 2022: HOW MALE INFERTILITY TREATMENT HAS CHANGED IN INSURANCE MEDICAL INSTITUTION -FROM THE QUESTIONNAIRE FOR JAPAN SOCIETY FOR REPRODUCTIVE MEDICINE MALE INFERTILITY SPECIAL INTEREST GROUP (SIG)-Reference-Cited by-同舟云学术

INSURANCE COVERAGE FOR INFERTILITY TREATMENT SINCE APRIL 2022: HOW MALE INFERTILITY TREATMENT HAS CHANGED IN INSURANCE MEDICAL INSTITUTION -FROM THE QUESTIONNAIRE FOR JAPAN SOCIETY FOR REPRODUCTIVE MEDICINE MALE INFERTILITY SPECIAL INTEREST GROUP (SIG)

Published:2023-07-20 Issue:3 Volume:114 Page:75-80
ISSN:0021-5287
Container-title:The Japanese Journal of Urology
language:en
Short-container-title:Jpn. j. urol

Author:

Takeshima Teppei¹²,Ando Satoshi¹³,Iwahata Toshiyuki¹⁴,Umemoto Yukihiro¹⁵,Kato Mayuko¹⁶,Kobayashi Hideyuki¹⁷,Komiya Akira¹⁶⁸,Shiraishi Koji¹⁹,Taniguchi Hisanori¹¹⁰,Chiba Koji¹¹¹,Tsujimura Akira¹¹²,Fukuhara Shinichiro¹¹³,Yumura Yasushi¹²

Affiliation:

1. Japan Society for Reproductive Medicine Male Infertility Special Interest Group (SIG)

2. Department of Urology, Reproduction Center, Yokohama City University Medical Center

3. Department of Urology, Jichi Medical University

4. International Center for Reproductive Medicine, Dokkyo Medical University Saitama Medical Center

5. Department of Urology, Nagoya City University West Medical Center

6. Department of Urology, Chiba University Graduate School of Medicine

7. Department of Urology, Toho University School of Medicine

8. Department of Urology, Kameda Medical Center

9. Department of Urology, Graduate School of Medicine, Yamaguchi University

10. Department of Urology and Andrology, Kansai Medical University

11. Division of Urology, Department of Surgery Related, Kobe University Graduate School of Medicine

12. Department of Urology, Juntendo University Urayasu Hospital

13. Department of Urology, Osaka University Graduate School of Medicine

Publisher

Japanese Urological Association

Link

https://www.jstage.jst.go.jp/article/jpnjurol/114/3/114_75/_pdf

Reference9 articles.

1. 1) 厚生労働省保険局医療課: 令和4年度診療報酬改定の概要不妊II (各論). https://www.mhlw.go.jp/content/12400000/000911820.pdf.

2. 2) WHO Director-General's opening remarks at the media briefing on COVID19.

3. 3) 日本生殖医学会HP: 「新型コロナウイルス感染症 (COVID-19) に対する日本生殖医学会からの声明」 (2020年4月1日版). http://www.jsrm.or.jp/announce/187.pdf.

4. 4) 伊丹祥, 影林頼, 大森千, 井上剛, 松村善, 三馬省: COVID-19蔓延が当院泌尿器科診療に与えた影響. 日本泌尿器科学会雑誌, 113, 83, 2022.

5. 5) Heinze A, Umari P, Basulto-Martínez M, Suárez-Ibarrola R, Liatsikos E, Rassweiler J, Guven S and Gozen AS: Impact of COVID-19 on Clinical and Academic Urological Practice: A Survey from European Association of Urology Section of Uro-technology. Eur Urol Open Sci, 21, 22, 2020.